The growing number of government measures to avoid certain diseases and epidemics is predicted to propel the global adult vaccines market forward. According to the National Health Mission, India is committed to the aim of measles elimination and rubella control, and thus, in 2017, the Measles Rubella (MR) vaccine was introduced in the country in a phased campaign style.
The Measles-Rubella (MR) campaign targets approximately 4.1 million children aged 9 months to 15 years (almost one-third of India's entire population), followed by two doses of regular immunisation at 9-12 months and 16-24 months. Rubella component is now routinely immunised as part of the MR vaccine.
Read More:
https://knackersblogger.blogspot.com/2022/10/adult-vaccines-market-size-share.html
